Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00820300 · ClinicalTrials.gov registry record · Phase 2
A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma
A Phase 2 study, sponsored by Mati Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 113
- Enrollment target
NCT00820300 is a Phase 2 study that has completed, run by Mati Therapeutics. The registered enrollment target is 113 participants.
The verdict
NCT00820300, a Phase 2 study, has completed, sponsored by Mati Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 113 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the Punctal Plug Delivery System is safe and effective in controlling intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Interventions
- DRUG Latanoprost-PPDS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00820300
The ClinicalTrials.gov registry entry for NCT00820300 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mati Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Latanoprost-PPDS is the first listed.
NCT00820300 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00820300 about?
NCT00820300 is a clinical study titled "A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma". The purpose of this study is to determine if the Punctal Plug Delivery System is safe and effective in controlling intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
What is the current status of trial NCT00820300?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 113 participants. The study started on 2009-01. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00820300?
The interventions under investigation include: Latanoprost-PPDS (DRUG).
Who is sponsoring clinical trial NCT00820300?
This trial is sponsored by Mati Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.